439692-89-4

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
Thieno[2,3-d]pyrimidin-4(3H)-one, 5-ethyl-6-methylis utilized as a chemical entity in pharmaceutical research and drug development due to its potential bioactivity. thieno[2,3-d]pyrimidin-4(3H)-one, 5-ethyl-6-methyl-'s unique structure suggests that it may play a role in modulating various biological processes, offering opportunities for the treatment of a range of diseases.
Used in the Development of Therapeutic Agents:
In the pharmaceutical industry, thieno[2,3-d]pyrimidin-4(3H)-one, 5-ethyl-6-methylis considered for its potential as a therapeutic agent. thieno[2,3-d]pyrimidin-4(3H)-one, 5-ethyl-6-methyl-'s ability to interact with biological targets could lead to the development of new drugs for treating diseases where existing treatments are insufficient or non-existent.
Used in Modulating Biological Processes:
The presence of the ethyl and methyl side chains in thieno[2,3-d]pyrimidin-4(3H)-one, 5-ethyl-6-methylmay affect how the compound interacts with biological systems. This makes it a candidate for use in modulating biological processes, which could be critical in the development of targeted therapies for specific conditions.

InChI:InChI=1S/C9H10N2OS/c1-3-6-5(2)13-9-7(6)8(12)10-4-11-9/h4H,3H2,1-2H3,(H,10,11,12)

Upstream product

• 77287-34-4 formamide 
• 4815-25-2 methyl 2-amino-4-ethyl-5-methylthiophene-3-carboxylate 
• 82546-91-6 ethyl 2-amino-4-ethyl-5-methyl-thiophene-3-carboxylate 
• 107-87-9 2-Pentanone 
• 64-18-6 formic acid 
• 4651-92-7 2‐amino‐4‐ethyl‐5‐methylthiophene‐3‐carbonitrile 
• 96-22-0 pentan-3-one 

Downstream Products

• 439692-90-7 4-chloro-5-ethyl-6-methylthiopheno[2,3-d]pyrimidine 

Relevant academic research and scientific papers

Synthesis, structural properties, and pharmacological evaluation of 2-(acylamino)thiophene-3-carboxamides and analogues thereof

We have previously reported the synthesis and the pharmacological characterization of a family of methyl 2-(acylamino)thiophene-3-carboxylates as GABAB positive allosteric modulators active both in vitro and in vivo. In the present work, we des

SUBSTITUTED 4-(SELENOPHEN-2(OR-3)-YLAMINO)PYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF

Selenophene compounds of formula (I) are described herein. In the compounds of Formula (I), ring A is a 6-membered aromatic fused ring, optionally containing one, two or three nitrogen atoms; a 5-membered heteroaromatic fused ring; or a mono- or bicyclic

Convenient and efficient synthesis of some novel fused thieno pyrimidines using gewald's reaction

Several functionalized thienopyrimidines were synthesized by a facile synthetic method, which includes Gewald's reaction, and were characterized by spectral and analytical data. These functionalized thienopyrimidines were converted to various new chemical

Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation, and structure-activity relationships

The synthesis and evaluation of new analogues of thieno[2,3-d]pyrimidin-4-yl hydrazones are described. 2-Pyrdinecarboxaldehyde [6-(tert-butyl)thieno[2,3-d]pyrimidine-4-yl]hydrazone derivatives have been identified as cyclin-dependent kinase 4 (CDK4) inhibitors. The potency, selectivity profile, and structure-activity relationship of this series of compounds are discussed.